This early-stage trial tests whether adding two experimental DNA vaccines (INO-5401 and INO-9012) and an immunotherapy drug (cemiplimab) to standard radiation and chemotherapy can help people with newly-diagnosed glioblastoma, an aggressive brain cancer. The study enrolls 52 part…
Phase: PHASE1, PHASE2 • Sponsor: Inovio Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 12:12 UTC